RBC Capital Further Trims Zynex (ZYXI) Target, Investor Lawsuit Looms – Hagens Berman
Zynex, Inc. (ZYXI)
NASDAQ:AMEX Investor Relations:
zynexmed.com/ir-overview
Company Research
Source: GlobeNewswire
SAN FRANCISCO, April 16, 2025 (GLOBE NEWSWIRE) -- Zynex, Inc. (NASDAQ: ZYXI), the Denver-based medical technology firm, is facing a deepening vortex of financial, regulatory and legal challenges, with RBC Capital Markets reportedly further reducing its outlook on the company’s stock. The company faces added pressure from a recently filed securities class action lawsuit, alleging the company made false and misleading statements regarding its revenue recognition practices and its relationship with Tricare, a major payer now temporarily suspending payments. Hagens Berman is investigating claims for alleged violations of the U.S. securities laws and urges investors who purchased Zynex securities and suffered substantial losses to submit your losses now. Class Period: Mar. 13, 2023 – Mar. 11, 2025Lead Plaintiff Deadline: May 19, 2025Visit: www.hbsslaw.com/investor-fraud/zyxi Contact the Firm Now: ZYXI@hbsslaw.com 844-916-0895 Dismal Q4 Results Prompts Multiple Downgrades On April 15
Show less
Read more
Impact Snapshot
Event Time:
ZYXI
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ZYXI alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ZYXI alerts
High impacting Zynex, Inc. news events
Weekly update
A roundup of the hottest topics
ZYXI
News
- Zynex (NASDAQ:ZYXI) had its "sell (e+)" rating reaffirmed by analysts at <a style="font-weight:bold" href="https://weissratings.com/">Weiss Ratings</a>.MarketBeat
- Zynex (NASDAQ:ZYXI) had its "sell (e+)" rating reaffirmed by analysts at <a style="font-weight:bold" href="https://weissratings.com/">Weiss Ratings</a>.MarketBeat
- Zynex Inc (ZYXI) Q3 2025 Earnings Call Highlights: Navigating Financial Challenges Amid ... [Yahoo! Finance]Yahoo! Finance
- Zynex, Inc. (ZYXI) Q3 2025 Earnings Call Prepared Remarks Transcript [Seeking Alpha]Seeking Alpha
- Zynex signals strategic turnaround and new leadership amid $60M debt maturity and revenue challenges [Seeking Alpha]Seeking Alpha
ZYXI
Sec Filings
- 11/20/25 - Form 3
- 11/17/25 - Form 10-Q
- 11/17/25 - Form 8-K
- ZYXI's page on the SEC website